Boris Julien

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

Fatima Teixeira-Clerc, Boris Julien, Pascale Grenard et al. · Nature Medicine · 2006 · 514 citations

Medicine, Pharmacology, Pharmacotherapy +16

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

Boris Julien, Pascale Grenard, Fatima Teixeira-Clerc et al. · Gastroenterology · 2005 · 459 citations · Full text

Medicine, Biochemistry, Pharmacology +13

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Javier Palazuelos, Tania Aguado, M. Ruth Pazos et al. · Brain · 2009 · 379 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Daily Cannabis Smoking as a Risk Factor for Progression of Fibrosis in Chronic Hepatitis C *

Christophe Hézode, Françoise Roudot‐Thoraval, Son Nguyen et al. · Hepatology · 2005 · 292 citations

Medicine, Pharmacology, Hepatology +16

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease

Cristina Blázquez, Anna Chiarlone, Onintza Sagredo et al. · Brain · 2010 · 197 citations · Full text

Life Sciences, Neurology, Neuroscience +17